chr6-90515416-C-T

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_145331.3(MAP3K7):c.*1085G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.357 (AC=54,190) in the gnomAD database across 151,652 control chromosomes, including 10,033 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.443. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10033 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

MAP3K7
NM_145331.3 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.906

Publications

11 publications found
Variant links:
Genes affected
MAP3K7 (HGNC:6859): (mitogen-activated protein kinase kinase kinase 7) The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
MAP3K7 Gene-Disease associations (from GenCC):
  • cardiospondylocarpofacial syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • frontometaphyseal dysplasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina
  • frontometaphyseal dysplasia 2
    Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_145331.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4429 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_145331.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K7
NM_145331.3
MANE Select
c.*1085G>A
3_prime_UTR
Exon 17 of 17NP_663304.1O43318-1
MAP3K7
NM_003188.4
c.*1085G>A
3_prime_UTR
Exon 16 of 16NP_003179.1O43318-2
MAP3K7
NM_145332.3
c.*1233G>A
3_prime_UTR
Exon 16 of 16NP_663305.1O43318-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K7
ENST00000369329.8
TSL:1 MANE Select
c.*1085G>A
3_prime_UTR
Exon 17 of 17ENSP00000358335.3O43318-1
MAP3K7
ENST00000369332.7
TSL:1
c.*1085G>A
3_prime_UTR
Exon 16 of 16ENSP00000358338.3O43318-2
MAP3K7
ENST00000369325.7
TSL:1
c.*1233G>A
3_prime_UTR
Exon 16 of 16ENSP00000358331.3O43318-3

Frequencies

GnomAD3 genomes
AF:
0.357
AC:
54134
AN:
151534
Hom.:
10024
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.449
Gnomad AMI
AF:
0.334
Gnomad AMR
AF:
0.346
Gnomad ASJ
AF:
0.468
Gnomad EAS
AF:
0.317
Gnomad SAS
AF:
0.423
Gnomad FIN
AF:
0.239
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.315
Gnomad OTH
AF:
0.380
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.357
AC:
54190
AN:
151652
Hom.:
10033
Cov.:
32
AF XY:
0.353
AC XY:
26168
AN XY:
74152
show subpopulations
African (AFR)
AF:
0.448
AC:
18550
AN:
41380
American (AMR)
AF:
0.347
AC:
5275
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.468
AC:
1621
AN:
3462
East Asian (EAS)
AF:
0.316
AC:
1631
AN:
5158
South Asian (SAS)
AF:
0.424
AC:
2041
AN:
4814
European-Finnish (FIN)
AF:
0.239
AC:
2523
AN:
10548
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.315
AC:
21314
AN:
67756
Other (OTH)
AF:
0.385
AC:
813
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1760
3519
5279
7038
8798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.333
Hom.:
11765
Bravo
AF:
0.365
Asia WGS
AF:
0.355
AC:
1235
AN:
3466

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.336
AC:
40898
AN:
121788
Turkish Variome
AF:
0.354
AC:
547
AN:
1546
Hom.:
99
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.307
AC:
2755
AN:
8960
Hom.:
424
ABraOM SABE-WGS-1171
AF:
0.335
AC:
784
AN:
2342
Hom.:
131

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
7.5
DANN
Benign
0.71
PhyloP100
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.